How to Take Bismuth-Based Quadruple Therapy for H. pylori
Take bismuth quadruple therapy for 14 days with the following regimen: PPI (standard dose) twice daily, bismuth 240-300 mg four times daily, metronidazole 400-500 mg three to four times daily, and tetracycline 500 mg four times daily, with all medications taken 30 minutes before meals on an empty stomach. 1
Specific Dosing Schedule
Components and Timing
PPI (Proton Pump Inhibitor): Take twice daily, 30 minutes before eating
- Standard doses: pantoprazole 40 mg, lansoprazole 30 mg, omeprazole 20 mg, esomeprazole 20 mg, or rabeprazole 20 mg 1
- Take on an empty stomach without other antacids
Bismuth: 240-300 mg (depending on formulation) four times daily
- Examples: bismuth subsalicylate 262 mg (2 tablets) or colloidal bismuth subcitrate 120 mg (1 tablet) 1
Metronidazole: 400-500 mg three to four times daily 1
- Can be substituted with tinidazole at equivalent dosing 1
Tetracycline: 500 mg four times daily 1
Duration
14 days is the preferred duration based on consensus guidelines from Toronto, Maastricht V/Florence, and ACG, as this achieves higher success rates than shorter courses 1. While 10-14 days may be acceptable if 10 days has been proven locally effective, the evidence supports 14 days for optimal first-attempt success 1.
Recent research confirms that 10-day regimens can achieve non-inferior efficacy (93.22% vs 93.74% eradication rates) with lower adverse effects 2, but guidelines prioritize the 14-day approach to maximize first-attempt success 1.
Critical Administration Details
Timing Considerations
- Take PPI 30 minutes before meals to optimize acid suppression 3
- Avoid concomitant use of H2-receptor antagonists or other antacids 3
- Maintain consistent timing throughout the day for all four-times-daily medications
Important Caveats
Common pitfalls to avoid:
Do not reduce duration below 14 days unless local data supports 10-day efficacy—the goal is to succeed on first attempt 1
Ensure four-times-daily dosing for bismuth and tetracycline—this is not negotiable for optimal efficacy 1
Do not skip the PPI—adequate acid suppression is essential for antibiotic stability and efficacy 3
Complete the full course even if symptoms improve—partial treatment leads to resistance 1
Why This Regimen Works
Bismuth quadruple therapy is recommended as first-line therapy by all major guidelines because it:
- Maintains high efficacy even with metronidazole-resistant strains 1
- Avoids clarithromycin (which has >15% resistance in many regions) 1
- Combines four agents with complementary mechanisms 4
- Achieves >90% eradication rates in intention-to-treat analysis 1
The regimen is particularly favored in areas with high dual resistance to clarithromycin and metronidazole 1.
Expected Side Effects
Most adverse events are mild and transient 1, 4:
- Nausea, epigastric discomfort
- Loose stools or diarrhea
- Fatigue, dizziness
- Metallic taste
- Dark stools (from bismuth—this is normal)
Compliance rates exceed 95-97% despite the complex regimen 5, 6. Side effects are generally tolerable and should not lead to discontinuation 4.
Alternative Formulations
A three-in-one single-capsule formulation is available in some regions, which simplifies administration and enhances adherence while maintaining >90% efficacy 4. If this is available, it represents the most convenient option while preserving therapeutic success.